Background
The efficacy of REGN-COV2 in preventing severe COVID-19 has been proven, and its use in outpatient and home settings is expanding.
Adverse events such as fever and decreased oxygen saturation, which are often seen after REGN-COV2 administration, are generally transient, but predicting these events is useful in developing a monitoring plan for patients.
Methods
We performed a retrospective analysis of 76 patients who received REGN-CoV2 between August and September 2021. The clinical course of the patients' fever and oxygen administration was collected from their medical records, and the patients were divided into two groups based on the presence or absence of these adverse events, and the underlying pathology and blood sampling data were compared. Parameters that showed significant differences were further examined by Fisher's exact probability test to see if the use of appropriate thresholds would significantly correlate with the occurrence of adverse events.
Findings
Of the 76 patients, 47 had fever of 38.5°C or higher within 24 hours after administration, and 27 of these patients had a body temperature of 37.5°C or lower before administration. Oxygen was required in 14 cases, 5 of which required oxygen more than 24 hours after administration of REGN-COV2, and additional treatment such as dexamethasone was given as a transition to moderate disease.
Among the parameters analyzed, except for fever before administration, lymphocyte count and IFNλ3 showed significant differences between the fever and non-fever groups. There was also a significant difference in ferritin and CRP between the oxygen required and non-required groups. This was also the case in the comparison excluding patients who had fever before administration. In addition to IFNλ3, ferritin, and CRP, there was a significant difference in LDH between the group that required additional treatment and the group that did not. Fisher's exact test was used to examine the prediction threshold for fever and non-fever groups. The sensitivity and specificity were 55% and 79%, respectively with odds ratio 4.746 (95% CI: 1.666 to 14.12) when lymphocytes counts <950/μL was used (p=0.004). Similarly, when IFNλ3>5.0 was used as the cutoff, sensitivity 72%, specificity 76%, odds ratio 8.220 (2.857 to 22.22; p<0.0001).
Interpretations
Fever and decreased oxygen saturation after administration of REGN-Cov2 were found to correlate with the severity factors of COVID-19 itself. Evaluation of these items at the time of administration is useful not only for predicting the severity of illness but also for the development of adverse events in patients.